🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
PGE
$PGEN
🔒 US EquitiesPrecigen Inc
AVG HISTORICAL GAP
+4.19%
MAX GAP RECORD
+31.29%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $PGEN
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$PGEN
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 04, 2026 Earnings Release 2026-08-04 (AFTER CLOSE) |
+7.50%
|
| May 13, 2026 Earnings Release 2026-05-13 (AFTER CLOSE) |
+10.36%
|
| Mar 25, 2026 Earnings Release 2026-03-25 (AFTER CLOSE) |
+31.29%
|
| Nov 13, 2025 Earnings Release 2025-11-13 (AFTER CLOSE) |
-2.07%
|
| Aug 12, 2025 Earnings Release 2025-08-12 (AFTER CLOSE) |
+1.67%
|
| May 14, 2025 Earnings Release 2025-05-14 (AFTER CLOSE) |
-0.78%
|
| Mar 19, 2025 Earnings Release 2025-03-19 (AFTER CLOSE) |
-0.56%
|
| Nov 14, 2024 Earnings Release 2024-11-14 (AFTER CLOSE) |
+4.55%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
5.6%
Bullish Gaps (7)
Bearish Gaps (4)
Neutral / Flat (4)
📖 Intelligence Summary
Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗